Víctor Urrea

2.2k total citations
49 papers, 911 citations indexed

About

Víctor Urrea is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Víctor Urrea has authored 49 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 26 papers in Virology and 10 papers in Molecular Biology. Recurrent topics in Víctor Urrea's work include HIV Research and Treatment (26 papers), HIV/AIDS Research and Interventions (13 papers) and HIV/AIDS drug development and treatment (13 papers). Víctor Urrea is often cited by papers focused on HIV Research and Treatment (26 papers), HIV/AIDS Research and Interventions (13 papers) and HIV/AIDS drug development and treatment (13 papers). Víctor Urrea collaborates with scholars based in Spain, United States and Belgium. Víctor Urrea's co-authors include M. Luz Calle, Núria Malats, Kristel Van Steen, Anne‐Laure Boulesteix, Julià Blanco, Bonaventura Clotet, Jorge Carrillo, Javier Martínez‐Picado, Jestinah Mahachie John and Tom Cattaert and has published in prestigious journals such as Journal of Clinical Investigation, Bioinformatics and PLoS ONE.

In The Last Decade

Víctor Urrea

43 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Víctor Urrea Spain 17 363 249 231 223 125 49 911
Francesca Salvatori Italy 18 268 0.7× 399 1.6× 291 1.3× 131 0.6× 139 1.1× 50 979
Krishnakumar Devadas United States 17 418 1.2× 250 1.0× 155 0.7× 69 0.3× 223 1.8× 40 890
Sher L. Hendrickson United States 15 192 0.5× 129 0.5× 95 0.4× 188 0.8× 60 0.5× 23 619
Jean-Philippe Goulet Canada 18 392 1.1× 375 1.5× 193 0.8× 155 0.7× 681 5.4× 27 1.4k
Michael F. Murray United States 14 585 1.6× 187 0.8× 80 0.3× 322 1.4× 134 1.1× 23 1.2k
Allyson Guimarães Costa Brazil 17 150 0.4× 153 0.6× 107 0.5× 178 0.8× 161 1.3× 85 787
Louise Swainson United States 15 235 0.6× 395 1.6× 172 0.7× 107 0.5× 657 5.3× 20 1.1k
Qigui Yu United States 26 407 1.1× 359 1.4× 269 1.2× 112 0.5× 588 4.7× 75 1.6k
Janice A. Williams United States 18 361 1.0× 79 0.3× 188 0.8× 72 0.3× 127 1.0× 28 1.1k
Randall C. Johnson United States 17 286 0.8× 755 3.0× 305 1.3× 294 1.3× 600 4.8× 26 1.5k

Countries citing papers authored by Víctor Urrea

Since Specialization
Citations

This map shows the geographic impact of Víctor Urrea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor Urrea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor Urrea more than expected).

Fields of papers citing papers by Víctor Urrea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor Urrea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor Urrea. The network helps show where Víctor Urrea may publish in the future.

Co-authorship network of co-authors of Víctor Urrea

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor Urrea. A scholar is included among the top collaborators of Víctor Urrea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor Urrea. Víctor Urrea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tarrés-Freixas, Ferran, Eva Riveira‐Muñoz, Dàlia Raϊch‐Regué, et al.. (2025). A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model. mBio. 16(5). e0072025–e0072025. 3 indexed citations
3.
Bailón, Lucía, Àngel Rivero, Pep Coll, et al.. (2025). Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program. Open Forum Infectious Diseases. 12(9). ofaf545–ofaf545.
4.
Pino, Rosa, Víctor Urrea, Marta Vidal, et al.. (2025). Tracking the soluble biomarkers of MIS-C and their association with clinical parameters and severity. Pediatric Research.
5.
Loste, Cora, Víctor Urrea, Ana Raquel Ortega Martínez, et al.. (2024). Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population. International Journal of Molecular Sciences. 25(20). 10930–10930. 1 indexed citations
6.
Ortiz, Raquel, Benjamin Trinité, Ferran Tarrés-Freixas, et al.. (2024). Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein. Viruses. 16(6). 987–987.
7.
Trinité, Benjamin, Eberhard Dürr, Carmen Aguilar‐Gurrieri, et al.. (2024). VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice. Vaccine. 42(15). 3474–3485. 6 indexed citations
8.
Ortiz, Raquel, Benjamin Trinité, Ferran Tarrés-Freixas, et al.. (2023). Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity. International Journal of Molecular Sciences. 24(10). 9025–9025. 4 indexed citations
9.
Aguilar‐Gurrieri, Carmen, Raquel Ortiz, Víctor Urrea, et al.. (2023). Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines. Cancer Immunology Immunotherapy. 72(7). 2113–2125. 9 indexed citations
10.
Pradenas, Edwards, Benjamin Trinité, Víctor Urrea, et al.. (2021). Stable neutralizing-antibody levels 6 months after mild and severe COVID-19 episode. 29(1). 88–88.
11.
Urrea, Víctor, Maria Luisa Rodrı́guez de la Concepción, Laura de la Fuente, et al.. (2021). A Longitudinal Analysis Reveals Early Activation and Late Alterations in B Cells During Primary HIV Infection in Mozambican Adults. Frontiers in Immunology. 11. 614319–614319. 2 indexed citations
12.
13.
Marfil, Sílvia, María Pernas, Cecilia Cabrera, et al.. (2019). HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic. Scientific Reports. 9(1). 5544–5544. 16 indexed citations
14.
Langhorst, Jost, Aina Casellas, Jorge Carrillo, et al.. (2019). Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection. PLoS ONE. 14(6). e0218000–e0218000. 10 indexed citations
15.
Rocafort, Muntsa, Marc Noguera-Julián, Javier Rivera, et al.. (2019). Evolution of the gut microbiome following acute HIV-1 infection. Microbiome. 7(1). 73–73. 93 indexed citations
16.
Urrea, Víctor, Jorge Carrillo, Laura de la Fuente, et al.. (2018). Dynamics of CD4 and CD8 T-Cell Subsets and Inflammatory Biomarkers during Early and Chronic HIV Infection in Mozambican Adults. Frontiers in Immunology. 8. 1925–1925. 24 indexed citations
17.
García, Elisabet, Víctor Urrea, Marta Massanella, et al.. (2017). Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery. Scientific Reports. 7(1). 11711–11711. 12 indexed citations
18.
Lishout, François Van, Jestinah Mahachie John, Elena S. Gusareva, et al.. (2013). An efficient algorithm to perform multiple testing in epistasis screening. BMC Bioinformatics. 14(1). 138–138. 22 indexed citations
19.
Cattaert, Tom, Víctor Urrea, Adam C. Naj, et al.. (2010). FAM-MDR: A Flexible Family-Based Multifactor Dimensionality Reduction Technique to Detect Epistasis Using Related Individuals. PLoS ONE. 5(4). e10304–e10304. 46 indexed citations
20.
Cattaert, Tom, M. Luz Calle, Scott Dudek, et al.. (2010). Model-Based Multifactor Dimensionality Reduction for detecting epistasis in case-control data in the presence of noise. Annals of Human Genetics. 75(1). 78–89. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Salvatori Breakdown of academic impact, for papers by Krishnakumar Devadas Breakdown of academic impact, for papers by Sher L. Hendrickson Breakdown of academic impact, for papers by Jean-Philippe Goulet Breakdown of academic impact, for papers by Michael F. Murray Breakdown of academic impact, for papers by Allyson Guimarães Costa Breakdown of academic impact, for papers by Louise Swainson Breakdown of academic impact, for papers by Qigui Yu Breakdown of academic impact, for papers by Janice A. Williams Breakdown of academic impact, for papers by Randall C. Johnson
Rankless by CCL
2026